JP3385408B2 - 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法 - Google Patents

新規蛋白質とその抗体、並びにその新規蛋白質の製造方法

Info

Publication number
JP3385408B2
JP3385408B2 JP16665992A JP16665992A JP3385408B2 JP 3385408 B2 JP3385408 B2 JP 3385408B2 JP 16665992 A JP16665992 A JP 16665992A JP 16665992 A JP16665992 A JP 16665992A JP 3385408 B2 JP3385408 B2 JP 3385408B2
Authority
JP
Japan
Prior art keywords
protein
cancer metastasis
glu
cells
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP16665992A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05310798A (ja
Inventor
完三 岩城
真平 牛尾
雅司 栗本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP16665992A priority Critical patent/JP3385408B2/ja
Priority to TW082103726A priority patent/TW240233B/zh
Priority to KR1019930008219A priority patent/KR940005672A/ko
Priority to EP19930303758 priority patent/EP0578356A3/en
Publication of JPH05310798A publication Critical patent/JPH05310798A/ja
Application granted granted Critical
Publication of JP3385408B2 publication Critical patent/JP3385408B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1253—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP16665992A 1992-05-14 1992-05-14 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法 Expired - Fee Related JP3385408B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP16665992A JP3385408B2 (ja) 1992-05-14 1992-05-14 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法
TW082103726A TW240233B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-05-14 1993-05-12
KR1019930008219A KR940005672A (ko) 1992-05-14 1993-05-13 신규 단백질과 그 항체 및 신규 단백질의 제조방법
EP19930303758 EP0578356A3 (en) 1992-05-14 1993-05-14 Mycoplasma protein promoting metastases and antibodies directed against it.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16665992A JP3385408B2 (ja) 1992-05-14 1992-05-14 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法

Publications (2)

Publication Number Publication Date
JPH05310798A JPH05310798A (ja) 1993-11-22
JP3385408B2 true JP3385408B2 (ja) 2003-03-10

Family

ID=15835362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16665992A Expired - Fee Related JP3385408B2 (ja) 1992-05-14 1992-05-14 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法

Country Status (4)

Country Link
EP (1) EP0578356A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3385408B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR940005672A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW240233B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
JP2007282630A (ja) * 2006-03-22 2007-11-01 Glycomedics Inc オリゴ糖鎖合成方法
US7737370B2 (en) 2006-07-31 2010-06-15 Hitachi Cable, Ltd. Electromagnetic shielding filter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3854160D1 (de) * 1987-09-16 1995-08-17 Int Genetic Eng Mit regressionsassoziierten antigenen in zusammenhangstehende methoden und verbindungen.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ＥＭＢＯ ＪＯＵＲＮＡＬ，Ｖｏｌ．７，Ｎｏ．１２（１９８８），ｐ．３９６３−３９７０
Ｊｏｕｒｎａｌ ｏｆ Ｃｅｌｌ Ｓｃｉｅｎｃｅ，Ｖｏｌ．９５，Ｎｏ．３（１９９０），ｐ．４９９−５０６

Also Published As

Publication number Publication date
KR940005672A (ko) 1994-03-22
TW240233B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-02-11
EP0578356A3 (en) 1994-11-23
JPH05310798A (ja) 1993-11-22
EP0578356A2 (en) 1994-01-12

Similar Documents

Publication Publication Date Title
Hand et al. Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody
US6121236A (en) Multivalent ligands which modulate angiogenesis
Plager et al. A novel and highly divergent homolog of human eosinophil granule major basic protein
JP5367905B2 (ja) ＤＬＫ１−Ｆｃ融合タンパク質を有効成分として含む癌転移抑制用組成物
JPH08231598A (ja) モノクローナル抗体
CN108893449B (zh) 杂交瘤细胞、抗人亲环素蛋白a的单克隆抗体及其应用
US5464936A (en) Compositions for identification of papillomavirus replication inhibitors
JP3385408B2 (ja) 新規蛋白質とその抗体、並びにその新規蛋白質の製造方法
US5208144A (en) Method for detection of human dna containing the gene encoding low density lipoprotein receptor
WO1989010133A1 (en) Stem cell inhibitors
AU601168B2 (en) Novel cell growth regulatory factor
US5731192A (en) Collagen COL4A6: gene, protein and method of detecting collagen deficiency
WO1991012272A1 (en) Protein factor
EP0333517A2 (en) Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor
JP4413611B2 (ja) Ｇ−ｃｓｆ遺伝子におけるエキソン３の領域の欠失について測定することを特徴とするガンの診断方法
CN108949730A (zh) 一种重组变构胶原酶的制备方法及其应用
KR100206061B1 (ko) 엠씨에이 28에이 32에 의해 인식되는 항원,씨티에이에이28에이32
JP2002508179A (ja) ポリペプチド、ポリヌクレオチド及びその用途
JP2690956B2 (ja) 生体由来のタンパク質
WO1992017500A1 (en) Novel megakaryocyte amplifying factor and production thereof
JPH0644877B2 (ja) 抗ヒト・フイブロネクチンモノクロ−ナル抗体
JPS59144796A (ja) 単一クロ−ン抗体
US5242807A (en) Recombinant gene encoding human Charcot-Leyden crystal protein
JPH06125784A (ja) モノクローナル抗体，ハイブリドーマ，その製造法および用途
CN116082509A (zh) 一种单域抗体及其制备方法和应用

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100110

Year of fee payment: 7

LAPS Cancellation because of no payment of annual fees